Damon Runyon Blog

Tagged: cancer research

February 6, 2019

Registration is now open for the 11th Annual Runyon 5K, which will be held on Saturday, May 11, 2019, at Yankee Stadium. 100% of donations raised will directly support bold and innovative scientists funded by the Damon Runyon Cancer Research Foundation.  Since the inaugural event in 2009, thousands of Runyon 5K participants have helped raise more than $5.2 million for breakthrough cancer research.

February 1, 2019

By Yung S. Lie, PhD,  President and CEO of the Damon Runyon Cancer Research Foundation

As recent headlines have declared, we have much to celebrate on World Cancer Day: the cancer death rate in the United States has fallen 27% from its peak in 1991. Many factors have contributed to this including the decrease in smoking and improved screening efforts. Tremendous advances in research and technology have been critical to this progress. Our ability to understand the genetic basis of cancer has rapidly accelerated over the last ten years, and now scientists are decoding cancer on an unprecedented scale. This has resulted in more effective precision medicine approaches, treating patients with the therapies to which their cancers are most likely to respond.

January 29, 2019

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative, early career researchers, named 18 new Damon Runyon Fellows at its fall Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($231,000 total) to work on innovative projects.

The Committee also named six new recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists. This award provides additional funding to scientists completing a Damon Runyon Fellowship Award who have greatly exceeded Damon Runyon’s highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer. Each awardee will receive $100,000 to be used toward their research.

January 24, 2019

Former Damon Runyon Fellow Gregory J. Hannon, PhD, and colleagues at the Cancer Research UK Cambridge Institute, have developed a new interactive, virtual reality 3D model of breast cancer.  A human tissue sample about the size of a pinhead was used to create the model, which can be magnified to appear several meters across, providing researchers an inside view of how breast cancer cells interact with surrounding healthy tissue. 

January 15, 2019

In 2018, William Raveis Real Estate raised an incredible $552,000 for cancer research. They have been a staunch supporter of Damon Runyon, nhosting several multi-state fundraising events. At the annual Raveis Ride + Walk, held September 30, 2018, at Calf Pasture Beach in Norwalk, Connecticut, Christy Jefremow bravely shared her story. 

January 10, 2019

Damon Runyon Cancer Research Foundation increases Junior Faculty Grants by 33%. Effective in 2019, the Damon Runyon-Rachleff Innovation and Damon Runyon Clinical Investigator Awards will be increased by 33% for new and current scientists. This investment allows the next generation of elite scientists to conduct work that will lay the foundation for careers filled with untold discoveries that are critical to finding new treatments and cures for patients. 

October 23, 2018

Approximately 450 supporters took part in Runyon Up, the first fundraising stair climb held at the newly opened Salesforce Tower in San Francisco on October 21. Climbers faced a unique vertical challenge in the 61-story building, the tallest in San Francisco, and were rewarded with breathtaking views from the top.

January 18, 2017

By Daniel Webster, PhD, Damon Runyon-Philip O’Bryan Montgomery Jr. MD Fellow

The Damon Runyon Cancer Research Foundation recently asked some of our current award recipients how cancer will be prevented, diagnosed, and/or treated differently in the future. What can a future cancer patient, say 10-20 years from now, expect to experience? Their responses were fascinating, and over the next few months we will share their visions for the future on this blog. 

November 7, 2016

Lorraine Egan, President & Chief Executive Officer, Damon Runyon Cancer Research Foundation

In this year’s Giving section of The New York Times, a prominent Silicon Valley donor, Cari Tuna, was quoted as follows:

“The biggest piece of advice I would give any donor is to be proactive,” Ms. Tuna said.  “Find the best charity for your values.  The charities that are the most aggressive and best at marketing aren’t necessarily the ones doing the most good.”

October 18, 2016

Philippe Soriano, PhD, Professor, Department of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai

I have been on the Damon Runyon Fellowship Awards Committee for three years and as a developmental biologist, who studies signaling pathways in mouse embryos, I do not strictly work on cancer. However, the Damon-Runyon Fellows are all very bright minds and are curious about all areas of science, so it was really fun to interact with them at the Fellows Retreat in San Jose, CA, from September 25-28, 2016.